Malaysia ensures data integrity during drug registration through stringent regulatory frameworks, including the Malaysian Drug Control Authority (DCA) guidelines. These involve rigorous data verification, Good Manufacturing Practice (GMP) compliance, electronic submission systems, and regular audits. Additionally, the National Pharmaceutical Regulatory Agency (NPRA) enforces strict documentation standards to maintain transparency and accuracy.
